Early detection of accrual problems in clinical trials (created 2006-06-30)

The most common reason why clinical trials fail is that they fall well below their goals for patient accrual. Institutional Review Boards (IRBs) are charged with the continual monitoring of clinical trials and they need to identify when these trials encounter problems with accrual. When do they "jump the shark" so to speak?

This webpage was originally published at the StATS website, which is currently unavailable. There is a dispute about the ownership of these pages, so I am only able to include a brief excerpt from this page.

This work is licensed under a Creative Commons Attribution 3.0 United States License. This page was written by Steve Simon and was last modified on 2008-11-10. Need more information? I have a page with general help resources. You can also browse for pages similar to this one at Category: Accrual problems in clinical trials.